-->
| Date | Analyst | Company | Last | Target | Call | Valuation |
| 06/18/18 | NRA | Asian Healthcare | 0.27 | 0.355 | Not Rated | PER24.2x FY19, EV/Ebitda16.18x FY19, Mid-point of target $0.33-$0.38 |
| 07/11/18 | UOB Kay Hian | Asian Healthcare | 0.24 | 0.33 | Buy | PER19.4x FY19 |
Discussion forum on Singapore stocks and current affairs.
https://www.globaltimes.cn/page/202509/1344216.shtml We've also conducted our due diligence on SCS and posted our analyses about this. h...
No comments:
Post a Comment